Published in Am J Respir Crit Care Med on November 30, 2006
Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care (2010) 1.85
The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care (2009) 1.83
Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med (2008) 1.76
Clinical review: Critical illness polyneuropathy and myopathy. Crit Care (2008) 1.69
Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury. Crit Care Med (2008) 1.65
Bench-to-bedside review: mobilizing patients in the intensive care unit--from pathophysiology to clinical trials. Crit Care (2009) 1.49
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med (2014) 1.49
Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care (2010) 1.45
Diaphragm weakness in mechanically ventilated critically ill patients. Crit Care (2013) 1.30
Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol (2011) 1.28
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle (2010) 1.11
Toward an integrated research agenda for critical illness in aging. Am J Respir Crit Care Med (2010) 1.10
Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol (2009) 1.06
Clinical review: intensive care unit acquired weakness. Crit Care (2015) 1.01
Blood glucose control in patients with severe sepsis and septic shock. World J Gastroenterol (2009) 1.01
Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol (2009) 1.01
Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients? Crit Care (2008) 1.00
Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin (2008) 0.99
Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care (2009) 0.96
Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care (2009) 0.96
Steroids for acute respiratory distress syndrome? Clin Chest Med (2014) 0.93
Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res (2014) 0.88
The impact of extended bed rest on the musculoskeletal system in the critical care environment. Extrem Physiol Med (2015) 0.86
Early Physical Rehabilitation in the ICU: A Review for the Neurohospitalist. Neurohospitalist (2012) 0.82
Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care (2015) 0.82
Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care (2011) 0.81
Critical illness neuromyopathy: from risk factors to prevention. Am J Respir Crit Care Med (2007) 0.80
A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome. Crit Care (2015) 0.80
Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth (2014) 0.80
Effects of early rehabilitation therapy on patients with mechanical ventilation. World J Emerg Med (2014) 0.79
Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy. Indian J Crit Care Med (2014) 0.78
Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress. Crit Care (2014) 0.78
Disease-Induced Skeletal Muscle Atrophy and Fatigue. Med Sci Sports Exerc (2016) 0.77
[Critical illness myopathy and polyneuropathy]. Med Klin Intensivmed Notfmed (2017) 0.77
Polyneuropathy and myopathy in the elderly. HSR Proc Intensive Care Cardiovasc Anesth (2012) 0.76
Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness. Front Pediatr (2016) 0.75
Critical illness myopathy in a cervical spine-injured patient. Spinal Cord Ser Cases (2016) 0.75
Review of Critical Illness Myopathy and Neuropathy. Neurohospitalist (2016) 0.75
Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit? Can J Hosp Pharm (2010) 0.75
Acute anoxic changes in peripheral nerve: anatomic and physiologic correlations. Brain Behav (2015) 0.75
Outcomes of ICU Patients With a Discharge Diagnosis of Critical Illness Polyneuromyopathy: A Propensity-Matched Analysis. Crit Care Med (2017) 0.75
The incidence of intensive care unit-acquired weakness syndromes: A systematic review. J Intensive Care Soc (2014) 0.75
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Early versus late parenteral nutrition in critically ill adults. N Engl J Med (2011) 12.10
Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med (2006) 7.26
Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet (2009) 6.44
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 6.01
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med (2003) 5.92
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med (2007) 4.40
ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr (2009) 4.11
Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09
Nutrition in the acute phase of critical illness. N Engl J Med (2014) 4.02
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis (2005) 3.96
Tight blood glucose control with insulin in the ICU: facts and controversies. Chest (2007) 3.79
Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes (2006) 3.56
Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med (2004) 3.42
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis (2009) 3.33
Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA (2012) 3.16
Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med (2010) 3.16
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut (2010) 2.91
From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med (2003) 2.84
Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med (2013) 2.81
Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med (2014) 2.68
Amino acid concentrations in critically ill children following cardiac surgery*. Pediatr Crit Care Med (2014) 2.65
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med (2007) 2.41
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med (2012) 2.39
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med (2006) 2.21
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med (2012) 2.14
Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest (2005) 2.11
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med (2009) 2.10
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med (2012) 2.06
Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg (2014) 2.04
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab (2003) 1.93
Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab (2003) 1.92
Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab (2009) 1.84
Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis (2007) 1.83
Clinical review: What is the role for autopsy in the ICU? Crit Care (2010) 1.79
Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med (2013) 1.78
Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet (2005) 1.78
Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Qual Saf Health Care (2010) 1.77
Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS (2004) 1.75
Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care (2013) 1.72
Clinical review: Critical illness polyneuropathy and myopathy. Crit Care (2008) 1.69
Long-term outcome of transcatheter embolotherapy for acute lower gastrointestinal hemorrhage. Am J Gastroenterol (2009) 1.69
Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol (2008) 1.67
Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab (2006) 1.60
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg (2010) 1.59
American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract (2004) 1.59
Novel methods to predict increased intracranial pressure during intensive care and long-term neurologic outcome after traumatic brain injury: development and validation in a multicenter dataset. Crit Care Med (2013) 1.58
Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med (2005) 1.58
Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med (2012) 1.57
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer (2009) 1.56
Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol (2013) 1.55
Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS (2008) 1.54
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab (2003) 1.50
Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med (2004) 1.50
Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab (2004) 1.50